No TCB008-related Adverse Events seen in any of the re-start patients 6 Patients received second dose, 3 Patients received third dose, 1 Patient received fourth dose EDINBURGH, Scotland, Sept. 12, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ:...
TCBP Announces First Patient Completed the Full Dose Regimen in ACHIEVE Clinical Trial
Seaking AlphaSeeking Alpha / Seaking Alpha 8 hours ago 1 Views
Comments